Skip to main content
Premium Trial:

Request an Annual Quote

... and Pays Roche $27.5M to License RT-PCR Technology for IVD Use

NEW YORK, July 17 (GenomeWeb News) - Beckman Coulter today said it has acquired an in vitro diagnostics product license to all of Roche's real-time PCR patents and pending patent applications.

 

In exchange Beckman Coulter will pay Roche a one-time license fee of $27.5 million and will also pay royalties on sales of all licensed products.

Beckman recently settled a patent-infringement suit with ABI that enabled it to license thermal cycler technology for RT-PCR instrumentation. The Roche license, meantime, "gives our company the intellectual property required to meet the molecular testing needs of routine labs for an automated, fully integrated system," Beckman CEO Scott Garrett said in a statement.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.